Skip to content

Application of Oliceridine in complex bronchoscopy under deep sedation/general anesthesia

Application of Oliceridine in complex bronchoscopy under deep sedation/general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100900
Enrollment
Unknown
Registered
2025-04-16
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory depression resulting by general anesthesia

Interventions

Oliceridine group:Oliceridine 2mg iv.
Sulfentanyl group:Sulfentanyl 0.2ug/kg iv.

Sponsors

Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients scheduled to undergo elective endobronchial ultrasound-guided needle biopsy, bronchoscopic cryotherapy or biopsy. 2.After preoperative evaluation, patients can be treated under deep sedation / general anesthesia. 3.Patient and their family members were informed and volunteered to participate in the study. 4.Age ranged from 18 to 75 years,ASA I~III.

Exclusion criteria

Exclusion criteria: 1.Patients who refused to participate in the study. 2.Patients with sleep apnea syndrome. 3.Patients with severe cardiac insufficiency or respiratory dysfunction. 4.Patients with liver and renal function impairment; intestinal obstruction; alcohol abuse or drug dependence. 5.Patients who cannot cooperate or difficulty communicating.

Design outcomes

Primary

MeasureTime frame
Incidence of perioperative respiratory depression;

Secondary

MeasureTime frame
Number of perioperative respiratory depression;Diagnosis rate;End-tidal Carbon Dioxide at the end of treatment;Duration of treatment;Satisfaction evaluation of patient and endoscopist;Hypoxemia within 6 hours after surgery;Incidence of postoperative nausea and vomiting;Effect of analgesia;

Countries

China

Contacts

Public Contactzhuyi

Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

sysu06389030@126.com+86 20 8382 7812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026